1 Min Read
July 11 (Reuters) - NEWRON PHARMACEUTICALS SPA:
* XADAGO(R) (SAFINAMIDE) NOW AVAILABLE IN U.S. FOR PARKINSON’S DISEASE PATIENTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.